Clinical Trials Directory

Trials / Terminated

TerminatedNCT04474925

Pre- Versus Post-operative SRS for Resectable Brain Metastases

A Randomized Controlled Trial of Pre-operative Versus Post-operative Stereotactic Radiosurgery for Patients With Surgically Resectable Brain Metastases

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
8 (actual)
Sponsor
AHS Cancer Control Alberta · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if performing radiotherapy (SRS) prior to surgery results in better treatment outcomes than performing surgery before radiotherapy for patients with brain metastases. Brain metastases occur when cancer cells from a primary cancer (e.g. lung, breast, colon) travel through the bloodstream and spread (metastasize) to the brain. As these new tumors grow they apply pressure and change how healthy brain tissue works. This can lead to a loss of brain function and worsening quality of life. Treatments for patients whose cancer has spread to the brain is often surgery, radiation therapy (radiotherapy) or a combination of both. Surgery is one the main treatments for brain tumors. To remove the tumor, a neurosurgeon makes an opening in the skull and attempts to the remove the entire tumor. If the tumor is too close to important brain tissue, the surgeon may attempt to remove part of the tumor. Removal of the tumor from the brain tissue is called resection. The complete or partial removal of tumor helps to relieve symptoms by reducing pressure on healthy tissues and reduces the amount of tumor that needs to be treated by radiotherapy. One type of radiotherapy used to treat brain metastases is stereotactic radiosurgery (SRS). SRS uses many focused radiation beams to treat tumors within the brain. Unlike surgery, there is no incision or cut being made. Instead, SRS uses an accurate map of your brain to deliver a precise beam of radiation to the tumors. The radiation damages the tumor cells forcing them to shrink and die off. The focused radiation beams also limit damage to healthy brain tissue minimizing side effects. Surgery followed by radiotherapy is a standard treatment for brain metastases. However, there are still risks associated with the combination of treatments. This study plans to investigate whether performing surgery prior to SRS results in improved quality of life and decreased side effects.

Conditions

Interventions

TypeNameDescription
PROCEDUREBrain SurgerySurgery to remove brain metastases
RADIATIONStereotactic RadiosurgerySRS uses many focused radiation beams to treat tumors within the brain

Timeline

Start date
2021-09-27
Primary completion
2025-04-07
Completion
2025-04-07
First posted
2020-07-17
Last updated
2025-07-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04474925. Inclusion in this directory is not an endorsement.